Odyssey
  • Homepage
  • Objectives
  • News
  • Publications
  • Privacy
    • Privacy Policy
    • Cookie Policy
  • Contact
  • Restricted
Select Page

First patient enrolled in ODYSSEY study

by odysseyadmin | Sep 21, 2016 | ODYSSEY

First patient enrolled in ODYSSEY study We are happy to announce that the first patient was enrolled in the ODYSSEY study by the team in Zimbabwe. We encourage all the sites to follow. Back to...

Recent Posts

  • ‘Because we all have to grow up;’ supporting adolescents to develop core competencies to transition towards managing their HIV independently
  • ODYSSEY team at Radboud receives the RIHS Societal Award 2020
  • DOLUTEGRAVIR-BASED ART IS SUPERIOR TO NNRTI/PI- BASED ART IN CHILDREN AND ADOLESCENTS
  • ODYSSEY trial finds new drug is better for treating children living with HIV
  • ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

Recent Comments

    Archives

    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • August 2020
    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • August 2019
    • July 2019
    • March 2019
    • July 2018
    • June 2018
    • April 2018
    • August 2017
    • September 2016

    Categories

    • ODYSSEY
    • Publication

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    This study is funded by ViiV Healthcare and the sponsor is Penta Foundation